[Ventricular thrombi in the chronic infarct stage: echocardiographic findings, clinical aspects, relations to

Zeitschrift Fur Kardiologie
|November 1, 1985
PubMed

Insights

Left ventricular thrombi are common after myocardial infarction, especially with anterior wall damage. Effective anticoagulant therapy promotes thrombus regression and prevents recurrence in post-infarction patients.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Thrombosis Research

Context:

  • Left ventricular mural thrombi are a recognized complication in the chronic phase of myocardial infarction.
  • Prevalence and characteristics of these thrombi vary based on infarct location and left ventricular function.

Purpose:

  • To investigate the prevalence, associated factors, and clinical outcomes of left ventricular mural thrombi in patients with chronic myocardial infarction.
  • To evaluate the impact of anticoagulant therapy on thrombus regression and recurrence.

Summary:

  • Left ventricular mural thrombi were detected in 10% of 1,383 patients with chronic myocardial infarction using 2D-echocardiography.
  • Thrombi were more frequent in anterior or combined anterior-posterior infarcts and left ventricular aneurysms, often associated with extensive myocardial damage and severe left ventricular dysfunction.
  • Systemic embolization occurred significantly more often in patients with thrombi (7.9%) compared to those without (0.7%).
  • At diagnosis, 90% of patients with thrombi were not on effective anticoagulant therapy. Follow-up showed thrombus regression in 93% of effectively anticoagulated patients, while persisting thrombi were seen in only 20% of those inadequately treated.
  • Discontinuation of anticoagulant therapy poses a high risk for thrombus recurrence.

Impact:

  • This study highlights the significant association between left ventricular thrombi and adverse events like systemic embolization in myocardial infarction survivors.
  • Findings underscore the critical role of timely diagnosis via 2D-echocardiography and effective anticoagulant management in improving outcomes and preventing complications.
  • The results emphasize the need for vigilant monitoring and sustained anticoagulant therapy in patients with post-myocardial infarction left ventricular thrombi.

Related Concept Videos

Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...